Catalyst Event
Boston Scientific Corp (BSX) · Other
From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)
5/8/2026, 12:00:00 AM
The U.S. FDA issued a Class I recall correction for certain ACCOLADE pacemakers on 2026-05-08 due to a software-related battery issue. High importance assigned due to potential for ≥10% price impact from safety concerns. Expected.
Korean Translation
2026-05-08 미국 FDA, 특정 ACCOLADE 심박동기 소프트웨어 관련 배터리 문제로 1등급 리콜 시정 조치 발표함. 안전 문제로 인한 10% 이상의 주가 영향이 예상되어 'High'로 분류함. 예상됨.
Related Recent Events
3SBio Inc (1530) · Earnings Release
First half 2026 earnings results are expected to be released around August 26, 2026, expected. High importance is estimated due to the significant impact of previous earnings growth on stock volatility.
8/26/2026, 12:00:00 AM
Cochlear Ltd (COH) · Earnings Release
Cochlear's full-year financial results for fiscal year 2026 are scheduled to be announced on August 18, 2026. Medium importance is estimated as annual earnings reports typically result in price movements exceeding 5%, scheduled.
8/18/2026, 12:00:00 AM
3SBio Inc (1530) · Other
The ex-dividend date for the final cash dividend of HKD 0.25 per share for the fiscal year 2025 is July 21, 2026, scheduled.
7/21/2026, 12:00:00 AM
Sino Biopharmaceutical Ltd (1177) · Other
The ex-dividend date for the proposed final dividend of HKD 0.05 per share is 2026-06-24, which is estimated to have a price impact of ≥1% scheduled.
6/24/2026, 12:00:00 AM
Innovent Biologics Inc (1801) · Other
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
6/5/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Medtronic to report Q4 and full fiscal year 2026 financial results, scheduled.
6/3/2026, 12:00:00 AM